Daniel Dale @ddale8
As the DeSantis administration rails against the FDA decision to limit use of monoclonal antibody treatments made by Regeneron and Eli Lilly, worth noting both companies say they agree with the feds that these drugs aren’t effective against omicron. Regeneron left, Lilly right: https://t.co/3vDj4ojWjm — PolitiTweet.org
Ron DeSantis @GovRonDeSantis
Without a shred of clinical data to support its decision, the Biden Administration has revoked the emergency use au… https://t.co/d3ctY210Wv
